Category : InternationalPublished on: November 02 2021
Share on facebook
Indonesia became the first country to approve the new vaccine for COVID-19 created by US-based Novavax.
The vaccine will be manufactured by the Serum Institute of India (SII), and deliveries will begin "immediately," according to a Novavax statement.
The vaccine would not need to be stored at extremely low temperatures, which would increase its availability to the world's poorest countries. This vaccine comes in two doses. It's made from lab-created copies of the coronavirus's spike protein, which serves as the virus's envelope.